CA2596387C - 18-membered macrocycles and analogs thereof - Google Patents
18-membered macrocycles and analogs thereof Download PDFInfo
- Publication number
- CA2596387C CA2596387C CA2596387A CA2596387A CA2596387C CA 2596387 C CA2596387 C CA 2596387C CA 2596387 A CA2596387 A CA 2596387A CA 2596387 A CA2596387 A CA 2596387A CA 2596387 C CA2596387 C CA 2596387C
- Authority
- CA
- Canada
- Prior art keywords
- tiacumicin
- opt
- formula
- compound
- antibiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Pest Control & Pesticides (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2005/002887 WO2006085838A1 (en) | 2005-01-31 | 2005-01-31 | 18-membered macrocycles and analogs thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2596387A1 CA2596387A1 (en) | 2006-08-17 |
CA2596387C true CA2596387C (en) | 2012-11-20 |
Family
ID=36793325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2596387A Active CA2596387C (en) | 2005-01-31 | 2005-01-31 | 18-membered macrocycles and analogs thereof |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1848273A4 (ja) |
JP (1) | JP5166040B2 (ja) |
KR (1) | KR101203118B1 (ja) |
CN (2) | CN102614207B (ja) |
AU (1) | AU2005327308B2 (ja) |
BR (1) | BRPI0519890A2 (ja) |
CA (1) | CA2596387C (ja) |
MX (2) | MX2007009196A (ja) |
TW (1) | TWI306097B (ja) |
WO (1) | WO2006085838A1 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7906489B2 (en) | 2004-05-14 | 2011-03-15 | Optimer Pharmaceuticals, Inc. | 18-membered macrocycles and analogs thereof |
US7378508B2 (en) * | 2007-01-22 | 2008-05-27 | Optimer Pharmaceuticals, Inc. | Polymorphic crystalline forms of tiacumicin B |
CA2626698C (en) * | 2005-10-21 | 2015-12-01 | Optimer Pharmaceuticals, Inc. | Method of treating clostridium difficile-associated diarrhea |
TWI482772B (zh) * | 2006-08-21 | 2015-05-01 | Astrazeneca Ab | 適合口服且包含三唑并[4,5-d]嘧啶衍生物之組合物 |
US20080176927A1 (en) | 2007-01-19 | 2008-07-24 | Optimer Pharmaceuticals, Inc. | Compositions of stable tiacumicins |
AU2012244278C1 (en) * | 2007-01-22 | 2014-11-06 | Merck Sharp & Dohme Llc | Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof |
ZA200905337B (en) * | 2007-01-22 | 2010-10-27 | Optimer Pharmaceuticals Inc | Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof |
TWI523654B (zh) | 2007-11-27 | 2016-03-01 | 默沙東藥廠 | 抗生素巨環化合物以及其製造及使用之方法 |
WO2012106722A2 (en) * | 2011-02-04 | 2012-08-09 | Optimer Pharmaceuticals, Inc. | Treatment of bacterial infections |
US8722863B2 (en) | 2012-05-10 | 2014-05-13 | Teva Pharmaceutical Works Ltd. | Solid state forms of fidaxomycin and processes for preparation thereof |
KR20150001802A (ko) * | 2012-05-10 | 2015-01-06 | 테바 파마슈티칼 웍스 엘티디. | 피닥소마이신의 고상 형태 및 이의 제조 방법 |
JO3464B1 (ar) | 2013-01-15 | 2020-07-05 | Astellas Pharma Europe Ltd | التركيبات الخاصة بمركبات التياكوميسين |
CN103275152B (zh) * | 2013-05-29 | 2015-11-18 | 华北制药集团新药研究开发有限责任公司 | 一种高纯度非达霉素的制备方法 |
HUE038426T2 (hu) | 2014-03-18 | 2018-10-29 | Xellia Pharmaceuticals Aps | Tiacumicin B új polimorfjai és új szilárd állapotai |
CN103897003B (zh) * | 2014-03-28 | 2016-07-06 | 华北制药集团新药研究开发有限责任公司 | 非达霉素晶型ii及其制备方法 |
UA122203C2 (uk) | 2014-05-09 | 2020-10-12 | Астеллас Фарма Юроп Лтд | Схема лікування із застосуванням сполуки тіакуміцину |
US10548912B2 (en) | 2015-07-03 | 2020-02-04 | Astellas Pharma Europe Ltd. | Dosage regimen for a tiacumicin compound |
CN105237599B (zh) * | 2015-10-09 | 2018-10-02 | 华北制药集团新药研究开发有限责任公司 | 闰年霉素a4晶体及其制备方法 |
CN110183502A (zh) * | 2019-05-28 | 2019-08-30 | 杭州华东医药集团新药研究院有限公司 | 一种非达霉素杂质及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1458512A (en) * | 1973-11-22 | 1976-12-15 | Lepetit Spa | Antibiotic substance |
US4918174A (en) * | 1986-09-26 | 1990-04-17 | Abbott Laboratories | Tiacumicin compounds |
US5583115A (en) * | 1995-05-09 | 1996-12-10 | Abbott Laboratories | Dialkyltiacumicin compounds |
US5767096A (en) * | 1996-07-12 | 1998-06-16 | Abbott Laboratories | Bromotiacumicin compounds |
US7507564B2 (en) | 2002-07-29 | 2009-03-24 | Optimer Pharmaceuticals, Inc. | Tiacumicin production |
SI2070530T1 (sl) * | 2004-05-14 | 2016-05-31 | Merck Sharp & Dohme Corp. | Zdravljenje bolezni, povezanih z uporabo antibiotikov |
-
2005
- 2005-01-31 MX MX2007009196A patent/MX2007009196A/es active IP Right Grant
- 2005-01-31 AU AU2005327308A patent/AU2005327308B2/en active Active
- 2005-01-31 CA CA2596387A patent/CA2596387C/en active Active
- 2005-01-31 WO PCT/US2005/002887 patent/WO2006085838A1/en active Application Filing
- 2005-01-31 CN CN201210032395.4A patent/CN102614207B/zh active Active
- 2005-01-31 JP JP2007553073A patent/JP5166040B2/ja active Active
- 2005-01-31 CN CN2005800487153A patent/CN101128114B/zh active Active
- 2005-01-31 MX MX2012009525A patent/MX340742B/es unknown
- 2005-01-31 BR BRPI0519890-9A patent/BRPI0519890A2/pt not_active Application Discontinuation
- 2005-01-31 EP EP05712354A patent/EP1848273A4/en not_active Ceased
- 2005-01-31 KR KR1020077019982A patent/KR101203118B1/ko active IP Right Grant
- 2005-05-17 TW TW094115942A patent/TWI306097B/zh active
Also Published As
Publication number | Publication date |
---|---|
EP1848273A1 (en) | 2007-10-31 |
BRPI0519890A2 (pt) | 2009-03-31 |
AU2005327308A1 (en) | 2006-08-17 |
WO2006085838A1 (en) | 2006-08-17 |
CN101128114B (zh) | 2012-03-28 |
KR20070110504A (ko) | 2007-11-19 |
MX340742B (es) | 2016-07-21 |
MX2007009196A (es) | 2009-02-25 |
TW200626585A (en) | 2006-08-01 |
TWI306097B (en) | 2009-02-11 |
AU2005327308B2 (en) | 2011-11-10 |
CN102614207A (zh) | 2012-08-01 |
JP5166040B2 (ja) | 2013-03-21 |
KR101203118B1 (ko) | 2012-11-20 |
CN101128114A (zh) | 2008-02-20 |
JP2008528582A (ja) | 2008-07-31 |
CN102614207B (zh) | 2016-01-13 |
EP1848273A4 (en) | 2010-02-24 |
CA2596387A1 (en) | 2006-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2596387C (en) | 18-membered macrocycles and analogs thereof | |
US8586551B2 (en) | 18-membered macrocycles and analogs thereof | |
JP6101010B2 (ja) | 抗生物質の使用に関連する疾患の治療 | |
JP5843344B2 (ja) | 大環状抗生物質化合物並びにその製造及び使用の方法 | |
AU2013245517B2 (en) | 18-membered macrocycles and analogs thereof | |
JP5825217B2 (ja) | 18員大環状化合物及びその類似化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |